TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11187921

Group type: EXPERIMENTAL
Intervention: L81‐10 protocol (1981‐1984)
Number of subjects: 1438

Group type: EXPERIMENTAL
Intervention: L84‐11 protocol (1984‐1989)
Number of subjects: 1438

Group type: EXPERIMENTAL
Intervention: L89‐12 protocol (1989‐1992)
Number of subjects: 1438

Group type: EXPERIMENTAL
Intervention: L92‐13 protocol (1992‐1995)
Number of subjects: 1438

Group type: COMPARATOR
Intervention: CNS relapse rates for L81‐10, L84‐11, L89‐12, L92‐13 protocols
Number of subjects: 1438

Group type: EXPERIMENTAL
Intervention: NCI risk criteria for B‐precursor ALL
Number of subjects: 1438

Group type: EXPERIMENTAL
Intervention: NCI risk criteria for T‐ALL
Number of subjects: 1438

Group type: EXPERIMENTAL
Intervention: Cranial irradiation
Number of subjects: 1438
Study: 9332112

Group type: EXPERIMENTAL
Intervention: Intravenous Magnesium sulfate (0.2 ml/kg of 50% MgSO4 as intravenous infusion over 35 minutes)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Intravenous Magnesium sulfate
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo (normal saline infusion in the same dose and at the same rate)
Number of subjects: 47
Study: 8441894

Group type: EXPERIMENTAL
Intervention: Lozenges
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 18
Study: 3741825

Group type: EXPERIMENTAL
Intervention: Intravenous lignocaine (1.5 mg kg‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29424007

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo-IMT
Number of subjects: 12

Group type: COMPARATOR
Intervention: Thoracic Load Carriage (LC)
Number of subjects: 12
Study: 26553486

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg day(-1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Continuation of standard insulin therapy
Number of subjects: 50
Study: 23753256

Group type: EXPERIMENTAL
Intervention: Regular self-weighing intervention (two telephone calls, offer of free weighing scales, encouragement to weigh weekly)
Number of subjects: 3768

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 3768

Group type: EXPERIMENTAL
Intervention: Regular self-weighing intervention
Number of subjects: 3768
Study: 23318127

Group type: EXPERIMENTAL
Intervention: Informational booklet (IB)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: IB + didactic discussions (DD)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: IB + imaginal and direct exposure desensitization (ET)
Number of subjects: 191

Group type: COMPARATOR
Intervention: IB
Number of subjects: 191

Group type: COMPARATOR
Intervention: DD
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: ET
Number of subjects: 191
Study: 19850640

Group type: EXPERIMENTAL
Intervention: High dose intensity doxorubicin-based regimens
Number of subjects: 8

Group type: COMPARATOR
Intervention: CHOP (control arm)
Number of subjects: 8
Study: 18226670

Group type: EXPERIMENTAL
Intervention: DMPA 150 mg intramuscularly
Number of subjects: 70
Study: 17238814

Group type: EXPERIMENTAL
Intervention: Topical ketorolac tromethamine 0.5%
Number of subjects: 30

Group type: COMPARATOR
Intervention: Artificial tear drop (placebo)
Number of subjects: 30
Study: 12571480

Group type: EXPERIMENTAL
Intervention: Iliac crest reconstruction using MacroPore sheet and Inductive Conductive Matrix (ICM)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No donor site reconstruction
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Iliac crest reconstruction
Number of subjects: 46
Study: 11004040

Group type: COMPARATOR
Intervention: Diprivan(TM)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Bisulfite-containing propofol 1.5 mg/kg IV
Number of subjects: 200
Study: 8823692

Group type: EXPERIMENTAL
Intervention: Aceclofenac, 100 mg bid orally
Number of subjects: 273

Group type: COMPARATOR
Intervention: Tenoxicam, 20 mg orally at bedtime
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Aceclofenac
Number of subjects: 273

Group type: COMPARATOR
Intervention: Tenoxicam
Number of subjects: 273
Study: 1349496

Group type: EXPERIMENTAL
Intervention: Celiprolol 200 mg daily for 7 days
Number of subjects: 16
Study: 3512461

Group type: EXPERIMENTAL
Intervention: 0.5% malathion lotion
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control lotion (vehicle)
Number of subjects: 119
Study: 31879229

Group type: EXPERIMENTAL
Intervention: Incubation for 90 min (group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Incubation for 180 min (group B)
Number of subjects: 100
Study: 29558782

Group type: EXPERIMENTAL
Intervention: Verum (Monapax syrup)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 27382456

Group type: EXPERIMENTAL
Intervention: Silymarin (70 mg) administered at three hours and 24 hours after pregnancy termination
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo administered at three hours and 24 hours after pregnancy termination
Number of subjects: 60
Study: 24802951

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (500 mg · day(‐1))
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 22526068

Group type: EXPERIMENTAL
Intervention: Cream containing green tea extract
Number of subjects: 10
Study: 16125495

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 0
Study: 12130401

Group type: EXPERIMENTAL
Intervention: Eccentric contractions in subjects with patellofemoral pain
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study: 9569477

Group type: EXPERIMENTAL
Intervention: Recombinant hepatitis B virus (HBV) vaccines administered at 2, 4, and 12 months of age, concurrent with OPV and DTP vaccination.
Number of subjects: 1237

Group type: COMPARATOR
Intervention: Whole cell DTP and three-component acellular DTaPs administered as part of the vaccination schedule.
Number of subjects: 1237

Group type: EXPERIMENTAL
Intervention: Antibody response measured by ELISA for HBsAg.
Number of subjects: 1237
Study: 7978174

Group type: EXPERIMENTAL
Intervention: Manual ventilation with Kuhn's T‐piece system and face mask (group A; n = 11)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with paediatric circle system, endotracheal tube, and positive end‐expiratory pressure (PEEP) 3 cm H2O (group D; n = 10)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Manual ventilation with paediatric circuit system and face mask (group C; n = 11)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Manual ventilation with endotracheal tube (group B; n = 10)
Number of subjects: 42
Study: 2729632

Group type: EXPERIMENTAL
Intervention: Single breath test (Crssb)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Volume recruitment maneuver (Crsvr)
Number of subjects: 18
Study: 1218170

Group type: EXPERIMENTAL
Intervention: etidocaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: bupivacaine
Number of subjects: 100
Study: 12471569

Group type: EXPERIMENTAL
Intervention: artesunate-atovaquone-proguanil
Number of subjects: 1596

Group type: COMPARATOR
Intervention: artesunate-mefloquine
Number of subjects: 1596

Group type: COMPARATOR
Intervention: atovaquone-proguanil-artesunate
Number of subjects: 1596

Group type: COMPARATOR
Intervention: atovaquone-proguanil
Number of subjects: 1596

Group type: COMPARATOR
Intervention: artesunate
Number of subjects: 1596

Group type: COMPARATOR
Intervention: mefloquine
Number of subjects: 1596
Study: 30661700

Group type: EXPERIMENTAL
Intervention: Vitamin A treatment (100,000 IU intramuscular daily for 7 days)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo treatment (blinded placebo daily for 7 days)
Number of subjects: 63
Study: 29353426

Group type: EXPERIMENTAL
Intervention: Dipyrone (1 g) administered preemptively before surgery
Number of subjects: 25

Group type: COMPARATOR
Intervention: Dipyrone (1 g) administered in the immediate postoperative period
Number of subjects: 25
Study: 27898166

Group type: COMPARATOR
Intervention: Standard triple therapy (7- to 14-day regimen with PPI, clarithromycin, and either amoxicillin or an imidazole)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: 10-day sequential therapy (5 days of PPI and amoxicillin followed by 5 days of PPI, clarithromycin, and an imidazole)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: 14-day sequential therapy (5 days of PPI and amoxicillin followed by 5 days of PPI, clarithromycin, and an imidazole)
Number of subjects: 257
Study: 24055350

Group type: EXPERIMENTAL
Intervention: 2 doses of Q-HPV vaccine at 0, 6 months (n=259)
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: 3 doses of Q-HPV vaccine at 0, 2, 6 months (n=260)
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: 3 doses of Q-HPV vaccine at 0, 2, 6 months (n=305)
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: 3 doses of Q-HPV vaccine (all subjects)
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: PsV NAb assay
Number of subjects: 824
Study: 23327034

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 microg/kg (group D)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline placebo (group P)
Number of subjects: 40
Study: 19656221

Group type: EXPERIMENTAL
Intervention: Topiramate 50 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/day
Number of subjects: 30
Study: 18806966

Group type: EXPERIMENTAL
Intervention: 50 mg SF‐TRE
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 100 mg SF‐TRE
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 200 mg SF‐TRE
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 16297562

Group type: EXPERIMENTAL
Intervention: Current illicit drug use (N=253)
Number of subjects: 2267

Group type: EXPERIMENTAL
Intervention: Past drug use (N=617)
Number of subjects: 2267

Group type: COMPARATOR
Intervention: Non-users (N=1397)
Number of subjects: 2267

Group type: EXPERIMENTAL
Intervention: Demographic factors (age, sex, SES)
Number of subjects: 2267

Group type: EXPERIMENTAL
Intervention: Prior pain
Number of subjects: 2267

Group type: EXPERIMENTAL
Intervention: HIV/AIDS illness burden
Number of subjects: 2267

Group type: EXPERIMENTAL
Intervention: Current substance use at baseline
Number of subjects: 2267

Group type: EXPERIMENTAL
Intervention: Previous illness burden
Number of subjects: 2267
Study: 12087523

Group type: EXPERIMENTAL
Intervention: Intranasal virosomal influenza vaccine
Number of subjects: 133

Group type: COMPARATOR
Intervention: No vaccination (control)
Number of subjects: 133
Study: 9459315

Group type: EXPERIMENTAL
Intervention: Idiopathic DVT
Number of subjects: 264

Group type: COMPARATOR
Intervention: Secondary DVT
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Recurrent venous thromboembolism
Number of subjects: 264

Group type: COMPARATOR
Intervention: Without recurrent venous thromboembolism
Number of subjects: 264
Study: 7707846

Group type: EXPERIMENTAL
Intervention: Excimer laser irradiation (lambda = 308 nm, pulsewidth: 20 ns, repetition rate: 10‐70 Hz, radiant exposure: 10‐50 mJ/mm2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser irradiation (lambda = 1064 nm, energy density: 21‐93 W/mm2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (nonirradiated menisci)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser meniscectomy (both excimer and Nd:YAG)
Number of subjects: 0
Study: 2675931

Group type: EXPERIMENTAL
Intervention: Computer Assisted Learning (CAL) program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lecture method
Number of subjects: 0
Study: 551921

Group type: EXPERIMENTAL
Intervention: Specific hypotensive therapy (Ht)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Untreated hypertensive group (Hu)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hospital sample (S)
Number of subjects: 0
Study: 31628576

Group type: EXPERIMENTAL
Intervention: Dual-axis rotational coronary angiography (DARCA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard coronary angiography (SA)
Number of subjects: 70
Study: 30707692

Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 334968
Study: 28039022

Group type: EXPERIMENTAL
Intervention: Active tDCS (2mA current for 20min/session over 10 sessions)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sham tDCS (control group)
Number of subjects: 84
Study: 25479182

Group type: EXPERIMENTAL
Intervention: Inpatient palliative care consult with follow-up as determined by provider
Number of subjects: 232

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 232
Study: 23218453

Group type: EXPERIMENTAL
Intervention: Secondhand smoke exposure for 1 hour
Number of subjects: 18
Study: 22335953

Group type: EXPERIMENTAL
Intervention: TC combined with endostar
Number of subjects: 126

Group type: COMPARATOR
Intervention: TC (control)
Number of subjects: 126
Study: 19371483

Group type: EXPERIMENTAL
Intervention: Alcohol (expect alcohol/receive alcohol)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo (expect alcohol/receive placebo)
Number of subjects: 91

Group type: COMPARATOR
Intervention: No-alcohol control (expect no alcohol/receive no alcohol)
Number of subjects: 91
Study: 16870035

Group type: EXPERIMENTAL
Intervention: Disposable bipolar diathermy
Number of subjects: 168

Group type: COMPARATOR
Intervention: Reusable monopolar diathermy
Number of subjects: 168
Study: 15099173

Group type: EXPERIMENTAL
Intervention: PAN intervention (physical activity and nutrition)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: PA intervention (physical activity alone)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 138
Study: 11544618

Group type: EXPERIMENTAL
Intervention: Cell Saver (CS) blood salvage during CABG surgery
Number of subjects: 45
Study: 9230648

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot (3.75 mg once a month for 3 months)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 7965538

Group type: EXPERIMENTAL
Intervention: High frequency oscillation at 10 Hz
Number of subjects: 12

Group type: COMPARATOR
Intervention: High frequency oscillation at 15 Hz
Number of subjects: 12
Study: 3677283

Group type: EXPERIMENTAL
Intervention: Neostigmine, 0.04 mg.kg‐1
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pyridostigmine, 0.2 mg.kg‐1
Number of subjects: 120

Group type: COMPARATOR
Intervention: Edrophonium, 0.54 mg.kg‐1
Number of subjects: 120
Study: 29198157

Group type: EXPERIMENTAL
Intervention: 1 mg estradiol valerate daily plus 4 mg medroxyprogesterone acetate on days 19–30
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 1 mg estradiol valerate daily plus 100 mg micronized progesterone on days 19–30
Number of subjects: 96

Group type: COMPARATOR
Intervention: 100 mg C. foetida extract daily
Number of subjects: 96
Study: 27716201

Group type: EXPERIMENTAL
Intervention: Point-of-care CRP testing in all children (1730 episodes)
Number of subjects: 3147

Group type: COMPARATOR
Intervention: Restricted CRP testing to children identified as at clinical risk (1417 episodes)
Number of subjects: 3147

Group type: EXPERIMENTAL
Intervention: CRP < 5 mg/L
Number of subjects: 3147

Group type: EXPERIMENTAL
Intervention: Children referred to hospital to rule out serious infection (80 children)
Number of subjects: 3147
Study: 23229841

Group type: EXPERIMENTAL
Intervention: Think Again advertisement
Number of subjects: 102
Study: 22520298

Group type: EXPERIMENTAL
Intervention: Winners with high baseline testosterone and low baseline cortisol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Losers
Number of subjects: 0
Study: 21412011

Group type: EXPERIMENTAL
Intervention: Pathology institute of campus II
Number of subjects: 700

Group type: COMPARATOR
Intervention: Pathology institute of campus I
Number of subjects: 700
Study: 18031594

Group type: EXPERIMENTAL
Intervention: Oral bisphosphonates (alendronate, risedronate, ibandronate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etidronate (administered with an extended between-dose interval)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-daily oral bisphosphonates
Number of subjects: 0
Study: 15731977

Group type: EXPERIMENTAL
Intervention: Information group (oral and written information about baby blues and postpartum depression)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group (no information provided)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Information group (EPDS scores)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group (EPDS scores)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Information group (self-evaluation of depression)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group (self-evaluation of depression)
Number of subjects: 169
Study: 12532113

Group type: EXPERIMENTAL
Intervention: Dietary omega-3 fatty acids supplementation
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: HDM avoidance intervention
Number of subjects: 616
Study: 10229740

Group type: EXPERIMENTAL
Intervention: Argatroban (10 mg/d IV) over 2 hours for 7 days
Number of subjects: 17

Group type: COMPARATOR
Intervention: None (no CVD group)
Number of subjects: 17
Study: 9367941

Group type: EXPERIMENTAL
Intervention: Drug formulation containing dimethylaminoethanolorotrate (DMAE), vitamins and minerals, 1 capsule per day for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 1758745

Group type: EXPERIMENTAL
Intervention: Theophylline treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group not receiving theophylline
Number of subjects: 19

Group type: COMPARATOR
Intervention: Nonasthmatic control group
Number of subjects: 19
Study: 6127349

Group type: EXPERIMENTAL
Intervention: Propranolol (beta-blocker)
Number of subjects: 4200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4200
Study: 30620370

Group type: EXPERIMENTAL
Intervention: Co-payment vouchers for clopidogrel or ticagrelor for 1 year (n=6436 patients)
Number of subjects: 11001

Group type: COMPARATOR
Intervention: Usual care without vouchers (n=4565 patients)
Number of subjects: 11001
Study: 29177980

Group type: EXPERIMENTAL
Intervention: LED irradiation (LEDI) on ipsilateral limb
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo on ipsilateral limb
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: LED irradiation (LEDI) on contralateral limb
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo on contralateral limb
Number of subjects: 12
Study: 27005901

Group type: EXPERIMENTAL
Intervention: Aphasia Action Success Knowledge Program
Number of subjects: 344

Group type: COMPARATOR
Intervention: Secondary Stroke Prevention Information Program
Number of subjects: 344
Study: 24768717

Group type: EXPERIMENTAL
Intervention: Hara‐Hachibu condition
Number of subjects: 11

Group type: COMPARATOR
Intervention: Fasting condition
Number of subjects: 11
Study: 22491810

Group type: EXPERIMENTAL
Intervention: 14 weeks of small-group, Tier 2 intervention
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Tier 1 data
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Logistic regression models
Number of subjects: 129
Study: 19409854

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (200 mg)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 17632309

Group type: EXPERIMENTAL
Intervention: LASEK
Number of subjects: 80

Group type: COMPARATOR
Intervention: LASIK
Number of subjects: 80
Study: 15693467

Group type: EXPERIMENTAL
Intervention: Usual care with massage
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Usual care with verbal coaching and slow breathing
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Usual care with massage and verbal coaching and slow breathing combined
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study: 11486930

Group type: EXPERIMENTAL
Intervention: Implicit learning of sequences (length 8)
Number of subjects: 0

Group type: COMPARATOR
Intervention: External precues introduced in a 3rd experiment
Number of subjects: 0
Study: 9754457

Group type: EXPERIMENTAL
Intervention: Neural network model for predicting heparin concentrations
Number of subjects: 119

Group type: COMPARATOR
Intervention: NONMEM model for predicting heparin concentrations
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Final NONMEM model using all data
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Volume of distribution and clearance
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Volume of distribution
Number of subjects: 119
Study: 8144738

Group type: EXPERIMENTAL
Intervention: Electric Toothbrush (ET)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manual Toothbrush (MT)
Number of subjects: 40
Study: 3046747

Group type: EXPERIMENTAL
Intervention: GL enzyme (hyaglosidase)
Number of subjects: 1488

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1488
Study: 1882908

Group type: EXPERIMENTAL
Intervention: Sucralfate 2 g, twice daily (b.i.d. group)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sucralfate 1 g, four times daily (q.i.d. group)
Number of subjects: 57
Study: 786314

Group type: EXPERIMENTAL
Intervention: Viloxazine (150-300 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 50
Study: 30288563

Group type: EXPERIMENTAL
Intervention: Oral isotretinoin (0.5 mg/kg) started on the 31st day after surgery, given every other day for 1 month and then daily for two additional months
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 27432355

Group type: EXPERIMENTAL
Intervention: MRI measures of synovitis
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: MRI measures of osteitis
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: MRI measures of bone erosion
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Improvements in synovitis and bone erosion
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Less improvement in synovitis and progression in MRI erosion at 52 weeks
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Progression on X-ray
Number of subjects: 291
Study: 26490434

Group type: EXPERIMENTAL
Intervention: Ongoing LMWH treatment for CAT
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cessation of LMWH at 6 months' treatment
Number of subjects: 32
Study: 24111502

Group type: EXPERIMENTAL
Intervention: n‐3 LCPUFA supplementation (fish oil capsules providing 900 mg daily)
Number of subjects: 706

Group type: COMPARATOR
Intervention: Control (matched vegetable oil capsules without n‐3 LCPUFA)
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: n‐3 LCPUFA supplementation (fish oil capsules)
Number of subjects: 706

Group type: COMPARATOR
Intervention: Control (matched vegetable oil capsules)
Number of subjects: 706